SEC Form 4 · accession 0000939798-17-000099
GT Biopharma, Inc. · GTBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Weldon
Officer — CFO · Director
Period of report
Sep 1, 2017
Accepted (ET)
Dec 1, 2017 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000109657
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | Sep 1, 2017 | A | 2,566,835 | $0.00 | A | 2,568,840 | D |
Table II — derivative securities
No Table II lines on this filing.